Correlation Between Anebulo Pharmaceuticals and ZyVersa Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and ZyVersa Therapeutics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and ZyVersa Therapeutics.

Diversification Opportunities for Anebulo Pharmaceuticals and ZyVersa Therapeutics

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Anebulo and ZyVersa is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and ZyVersa Therapeutics

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the ZyVersa Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.9 times less risky than ZyVersa Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The ZyVersa Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  118.00  in ZyVersa Therapeutics on November 9, 2024 and sell it today you would earn a total of  6.00  from holding ZyVersa Therapeutics or generate 5.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  ZyVersa Therapeutics

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
ZyVersa Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Anebulo Pharmaceuticals and ZyVersa Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and ZyVersa Therapeutics

The main advantage of trading using opposite Anebulo Pharmaceuticals and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.
The idea behind Anebulo Pharmaceuticals and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data